• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Marcela G. del Carmen, MD


  • Joseph N, Clark RM, Dizon DS, Lee MS, Goodman A, Boruta D, Schorge JO, Del Carmen MG, Growdon WB.
    Delay in Chemotherapy Administration Impacts Survival in Elderly Patients with Epithelial Ovarian Cancer.
    Gynecol Oncol. 2015 Mar 31.
  • Del Carmen MG, Rice LW, Schmeler KM.
    Global health perspective on gynecologic oncology.
    Gynecol Oncol. 2015 Mar 14.
  • Rauh-Hain JA, Buskwofie A, Clemmer J, Boruta DM, Schorge JO, Del Carmen MG.
    Racial disparities in treatment of high-grade endometrial cancer in the medicare population.
    Obstet Gynecol. 2015 Apr;125(4):843-51.
  • Clark RM, Lee MS, Alejandro Rauh-Hain J, Hall T, Boruta DM, Del Carmen MG, Goodman A, Schorge JO, Growdon WB.
    Surgical Apgar Score and prediction of morbidity in women undergoing hysterectomy for malignancy.
    Gynecol Oncol. 2015 Mar;136(3):516-20.
  • Del Carmen MG, Rice LW.
    Underrepresentation of women in clinical trials: why gynecologic oncologists are worried.
    Obstet Gynecol. 2015 Mar;125(3):616-9.
  • Foley OW, Rauh-Hain JA, Clemmer J, Clark RM, Hall T, Diver EJ, Schorge JO, del Carmen MG.
    Trends in the treatment of uterine leiomyosarcoma in the Medicare population.
    Int J Gynecol Cancer. 2015 Mar;25(3):453-8.
  • Linkov F, Edwards RP, Althouse A, Rauh-Hain JA, Del Carmen MG, Freese KE, Kelley JL, Olawaiye AB.
    Obesity, lymphadenectomy and survival outcomes in intermediate to high-risk, early-stage endometrial cancer patients.
    Future Oncol. 2015 Feb;11(4):607-15.
  • Sisodia RM, Del Carmen MG, Boruta DM.
    Role of minimally invasive surgery in the management of adnexal masses.
    Clin Obstet Gynecol. 2015 Mar;58(1):66-75.
  • Rauh-Hain JA, Goodman A, Boruta DM, Schorge JO, Horowitz NS, del Carmen MG.
    Endometrial stromal sarcoma: a clinicopathologic study of 29 patients.
    J Reprod Med.;59(11-12):547-52.
  • Owusu-Darko S, Rauh-Hain JA, Horowitz NS, Goodman A, Schorge JO, Del Carmen MG.
    Comparison of outcomes in patients with early-stage mucinous endometrial cancer and those with endometrioid endometrial cancer, with and without adjuvant therapy.
    J Reprod Med.;59(11-12):527-33.
  • George S, Barysauskas C, Serrano C, Oduyebo T, Rauh-Hain JA, Del Carmen MG, Demetri GD, Muto MG.
    Retrospective cohort study evaluating the impact of intraperitoneal morcellation on outcomes of localized uterine leiomyosarcoma.
    Cancer. 2014 Jun 12.
  • Vargas R, Rauh-Hain JA, Clemmer J, Clark RM, Goodman A, Growdon WB, Schorge JO, Del Carmen MG, Horowitz NS, Boruta DM.
    Tumor size, depth of invasion, and histologic grade as prognostic factors of lymph node involvement in endometrial cancer: A SEER analysis.
    Gynecol Oncol. 2014 May;133(2):216-20.
  • Worley MJ, Guseh SH, Rauh-Hain JA, Esselen KM, Muto MG, Feltmate CM, Berkowitz RS, Del Carmen MG, Schorge JO, Horowitz NS.
    What is the optimal treatment for obese patients with advanced ovarian carcinoma?.
    Am J Obstet Gynecol. 2014 Apr 1.
  • Foley OW, Rauh-Hain JA, Clark RM, Goodman A, Growdon WB, Boruta DM, Schorge JO, Del Carmen MG.
    Intraoperative Radiation Therapy in the Management of Gynecologic Malignancies.
    Am J Clin Oncol. 2014 Mar 28.
  • Guseh SH, Rauh-Hain JA, Tambouret RH, Davis M, Clark RM, Boruta DM, Goodman A, Growdon WB, Schorge JO, del Carmen MG.
    Transitional cell carcinoma of the ovary: a case-control study.
    Gynecol Oncol. 2014 Mar;132(3):649-53.
  • Del Carmen MG.
    Positive peritoneal cytology in patients with endometrial cancer: Continued controversy despite shift in staging.
    Cancer Cytopathol. 2014 Feb 27.
  • Garrett LA, Growdon WB, Goodman A, Boruta DM, Schorge JO, del Carmen MG.
    Endometriosis-associated ovarian malignancy: a retrospective analysis of presentation, treatment, and outcome.
    J Reprod Med.;58(11-12):469-76.
  • Oduyebo T, Rauh-Hain AJ, Meserve EE, Seidman MA, Hinchcliff E, George S, Quade B, Nucci MR, Del Carmen MG, Muto MG.
    The value of re-exploration in patients with inadvertently morcellated uterine sarcoma.
    Gynecol Oncol. 2014 Feb;132(2):360-5.
  • Jeudin P, Liveright E, Del Carmen MG, Perkins RB.
    Race, ethnicity, and income factors impacting human papillomavirus vaccination rates.
    Clin Ther. 2014 Jan 1;36(1):24-37.
  • Rauh-Hain JA, Vargas RJ, Clemmer J, Clark RM, Bradford LS, Growdon WB, Goodman A, Boruta DM, Schorge JO, Del Carmen MG.
    Mucinous Adenocarcinoma of the Endometrium Compared With Endometrioid Endometrial Cancer: A SEER Analysis.
    Am J Clin Oncol. 2014 Jan 2.
  • Rauh-Hain JA, Clemmer J, Clark RM, Bradford LS, Growdon WB, Goodman A, Boruta DM, Schorge JO, del Carmen MG.
    Racial disparities and changes in clinical characteristics and survival for vulvar cancer over time.
    Am J Obstet Gynecol. 2013 Nov;209(5):468.e1-468.e10.
  • Rauh-Hain JA, Davis M, Clemmer J, Clark RM, Growdon WB, Goodman AK, Boruta DM, Schorge JO, del Carmen MG.
    Prognostic determinants in patients with uterine and ovarian clear cell carcinoma: a SEER analysis.
    Gynecol Oncol. 2013 Nov;131(2):404-9.
  • Rauh-Hain JA, Clemmer JT, Bradford LS, Clark RM, Growdon WB, Goodman A, Boruta DM, Schorge JO, del Carmen MG.
    Racial disparities in cervical cancer survival over time.
    Cancer. 2013 Oct 15;119(20):3644-52.
  • Rauh-Hain JA, Diver EJ, Clemmer JT, Bradford LS, Clark RM, Growdon WB, Goodman AK, Boruta DM, Schorge JO, del Carmen MG.
    Carcinosarcoma of the ovary compared to papillary serous ovarian carcinoma: a SEER analysis.
    Gynecol Oncol. 2013 Oct;131(1):46-51.
  • Rauh-Hain JA, Guseh SH, Esselen KM, Growdon WB, Schorge JO, Horowitz NS, Krasner CN, del Carmen MG, Birrer MJ, Dizon DS.
    Patterns of recurrence in patients treated with bevacizumab in the primary treatment of advanced epithelial ovarian cancer.
    Int J Gynecol Cancer. 2013 Sep;23(7):1219-25.
  • Rauh-Hain JA, Shoni M, Schorge JO, Goodman A, Horowitz NS, del Carmen MG.
    Prognostic determinants in patients with uterine and ovarian carcinosarcoma.
    J Reprod Med.;58(7-8):297-304.
  • Rauh-Hain JA, Oduyebo T, Diver EJ, Guseh SH, George S, Muto MG, del Carmen MG.
    Uterine leiomyosarcoma: an updated series.
    Int J Gynecol Cancer. 2013 Jul;23(6):1036-43.
  • Diver E, O'Connor O, Garrett L, Boruta D, Goodman A, Del Carmen M, Schorge J, Mueller P, Growdon W.
    Modest benefit of total parenteral nutrition and chemotherapy after venting gastrostomy tube placement.
    Gynecol Oncol. 2013 May;129(2):332-5.
  • Jeudin P, Liveright E, Del Carmen MG, Perkins RB.
    Race, ethnicity and income as factors for HPV vaccine acceptance and use.
    Hum Vaccin Immunother. 2013 Apr 9;9(7).
  • Rauh-Hain JA, Nitschmann CC, Worley MJ, Bradford LS, Berkowitz RS, Schorge JO, Campos SM, Del Carmen MG, Horowitz NS.
    Platinum resistance after neoadjuvant chemotherapy compared to primary surgery in patients with advanced epithelial ovarian carcinoma.
    Gynecol Oncol. 2013 Apr;129(1):63-8.
  • del Carmen MG, Avila-Wallace M.
    Effect of health care disparities on screening.
    Clin Obstet Gynecol. 2013 Mar;56(1):65-75.
  • Foley OW, Rauh-Hain JA, del Carmen MG.
    The role of intraoperative radiation therapy in the management of recurrent and locally advanced gynecologic cancers.
    Int J Gynecol Cancer. 2013 Jan;23(1):9-15.
  • Del Carmen MG, Birrer M, Schorge JO.
    Uterine papillary serous cancer: A review of the literature.
    Gynecol Oncol. 2012 Dec;127(3):651-61.
  • del Carmen MG, Micha J, Small L, Street DG, Londhe A, McGowan T.
    A phase II clinical trial of pegylated liposomal doxorubicin and carboplatin plus bevacizumab in patients with platinum-sensitive recurrent ovarian, fallopian tube, or primary peritoneal cancer.
    Gynecol Oncol. 2012 Sep;126(3):369-74.
  • Diver EJ, Rauh-Hain JA, Del Carmen MG.
    Total pelvic exenteration for gynecologic malignancies.
    Int J Surg Oncol. 2012;2012:693535.
  • Rauh-Hain JA, Growdon WB, Rodriguez N, Goodman AK, Boruta DM, Schorge JO, Horowitz NS, Del Carmen MG.
    Carcinosarcoma of the ovary: A case-control study.
    Gynecol Oncol. 2011 Mar 18.
  • McCann CK, Growdon WB, Munro EG, Del Carmen MG, Boruta DM, Schorge JO, Goodman A.
    Prognostic Significance of Splenectomy as Part of Initial Cytoreductive Surgery in Ovarian Cancer.
    Ann Surg Oncol. 2011 Mar 22.
  • Schorge JO, McCann C, Del Carmen MG.
    Surgical debulking of ovarian cancer: what difference does it make?.
    Rev Obstet Gynecol. 2010;3(3):111-7.
  • Rauh-Hain JA, Growdon WB, Schorge JO, Goodman AK, Boruta DM, McCann C, Horowitz NS, del Carmen MG.
    Prognostic determinants in patients with stage IIIC and IV uterine papillary serous carcinoma.
    Gynecol Oncol. 2010 Nov;119(2):299-304.
  • Allen JD, Othus MK, Shelton RC, Li Y, Norman N, Tom L, del Carmen MG.
    Parental decision making about the HPV vaccine.
    Cancer Epidemiol Biomarkers Prev. 2010 Sep;19(9):2187-98.
  • Rauh-Hain JA, Del Carmen MG.
    Treatment for advanced and recurrent endometrial carcinoma: combined modalities.
    Oncologist. 2010;15(8):852-61.
  • Chapman E, Venkat P, Ko E, Orezzoli JP, Del Carmen M, Garner EI.
    Use of multimedia as an educational tool to improve human papillomavirus vaccine acceptability-A pilot study.
    Gynecol Oncol. 2010 Aug 1;118(2):103-7.
  • Rauh-Hain JA, Olawaiye AB, Munro M, Ko E, Alarcon IA, Del Carmen MG, Duska L.
    Role of computed tomography in the surgical management of patients with bowel obstruction secondary to recurrent ovarian carcinoma.
    Ann Surg Oncol. 2010 Mar;17(3):853-60.
  • Alejandro Rauh-Hain J, Olawaiye AB, Munro EG, Ko E, Alarcon IA, Del Carmen MG, Duska L.
    Role of Computed Tomography in the Surgical Management of Patients with Bowel Obstruction Secondary to Recurrent Ovarian Carcinoma.
    Ann Surg Oncol. 2009 Nov 18.
  • Na YJ, Farley J, Zeh A, del Carmen M, Penson R, Birrer MJ.
    Ovarian cancer: markers of response.
    Int J Gynecol Cancer. 2009 Dec;19 Suppl 2:S21-9. Review.
  • Watts L, Joseph N, Velazquez A, Gonzalez M, Munro E, Muzikansky A, Rauh-Hain JA, Del Carmen MG.
    Understanding barriers to cervical cancer screening among Hispanic women.
    Am J Obstet Gynecol. 2009 Aug;201(2):199.e1-8.
  • Orezzoli JP,Sioletic S,Olawaiye A,Oliva E,del Carmen MG.
    Stage II endometrioid adenocarcinoma of the endometrium: clinical implications of cervical stromal invasion.
    Gynecol Oncol. 2009 Jun;113(3):316-23.
  • Goldstein MA,Goodman A,del Carmen MG,Wilbur DC.
    Case records of the Massachusetts General Hospital. Case 10-2009. A 23-year-old woman with an abnormal Papanicolaou smear.
    N Engl J Med. 2009 Mar 26;360(13):1337-44.
  • Pandharipande PV,Choy G,del Carmen MG,Gazelle GS,Russell AH,Lee SI.
    MRI and PET/CT for triaging stage IB clinically operable cervical cancer to appropriate therapy: decision analysis to assess patient outcomes.
    AJR Am J Roentgenol. 2009 Mar;192(3):802-14.
  • Watts LA,Joseph N,Wallace M,Rauh-Hain JA,Muzikansky A,Growdon WB,del Carmen MG.
    HPV vaccine: A comparison of attitudes and behavioral perspectives between Latino and non-Latino women.
    Gynecol Oncol. 2009 Mar;112(3):577-82.
  • Olawaiye AB,Rauh-Hain JA,Withiam-Leitch M,Rueda B,Goodman A,del Carmen MG.
    Utility of pre-operative serum CA-125 in the management of uterine papillary serous carcinoma.
    Gynecol Oncol. 2008 Sep;110(3):293-8.
  • del Carmen, MG.
    Primary squamous carcinoma of the uterine cervix: Diagnosis and management.
    Harrison's Manual of Oncology (Bruce A. Chabner, Dan L. Longo, Thomas J. Lynch Eds)..
  • del Carmen MG, Halpern EF, Kopans DB, Moy B, Moore RH, Goss PE, Hughes KS.
    Mammographic breast density and race.
    AJR Am J Roentgenol. 2007 Apr;188(4):1147-50.
  • del Carmen MG, Findley M, Muzikansky A, Roche M, Verrill CL, Horowitz N, Seiden MV.
    Demographic, risk factor, and knowledge differences between Latinas and non-Latinas referred to colposcopy.
    Gynecol Oncol. 2007 Jan;104(1):70-6.
  • Colantonio SE, Fuster V, Del Carmen M, Lascano JG.
    Isonymic relationships in ethno-social categories (Argentinian colonial period) including illegitimate reproduction.
    J Biosoc Sci. 2006 May;38(3):381-9.
  • del Carmen MG, Rizvi I, Chang Y, Moor AC, Oliva E, Sherwood M, Pogue B, Hasan T.
    Synergism of epidermal growth factor receptor-targeted immunotherapy with photodynamic treatment of ovarian cancer in vivo.
    J Natl Cancer Inst. 2005 Oct 19;97(20):1516-24.
  • del Carmen MG, Joffe S.
    Informed consent for medical treatment and research: a review.
    Oncologist. 2005 Sep;10(8):636-41.
  • del Carmen MG, Fuller AF, Matulonis U, Horick NK, Goodman A, Duska LR, Penson R, Campos S, Roche M, Seiden MV.
    Phase II trial of anastrozole in women with asymptomatic müllerian cancer.
    Gynecol Oncol. 2003 Dec;91(3):596-602.
  • Del Carmen MG, Smith Sehdev AE, Fader AN, Zahurak ML, Richardson M, Fruehauf JP, Montz FJ, Bristow RE.
    Endometriosis-associated ovarian carcinoma: differential expression of vascular endothelial growth factor and estrogen/progesterone receptors.
    Cancer. 2003 Oct 15;98(8):1658-63.
  • del Carmen MG, Hughes KS, Halpern E, Rafferty E, Kopans D, Parisky YR, Sardi A, Esserman L, Rust S, Michaelson J.
    Racial differences in mammographic breast density.
    Cancer. 2003 Aug 1;98(3):590-6.
  • del Carmen MG, McIntyre JF, Fuller AF, Nikrui N, Goodman A.
    Intraoperative radiation therapy in the treatment of pelvic gynecologic malignancies: a review of fifteen cases.
    Gynecol Oncol. 2000 Dec;79(3):457-62.
  • del Carmen MG, Montz FJ, Bristow RE, Bovicelli A, Cornelison T, Trimble E.
    Ethnic differences in patterns of care of stage 1A(1) and stage 1A(2) cervical cancer: a SEER database study.
    Gynecol Oncol. 1999 Oct;75(1):113-7.